BarcikowskiB.CarlsonJ.WilsonL.McCrackenJ. (1974). The effect of endogenous and exogenous estradiol-17β on the release of prostaglandin F2α from the ovine uterus. Endocrinology, 95, 1340.
2.
BootJ. R.CockerillA. F.DawsonW.MallenD. N. B.OsborneD. J. (1978). Modification of prostaglandin and thromboxane release by immunological sensitisation and successive immunological challenges from guinea-pig lung. International Archives of Allergy and applied Immunology, 57, 159.
3.
FitzpatrickF. A.GormanR. R. (1977). Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2. Prostaglandins, 14, 881.
4.
FrölichJ. C.WilsonT. W.SweetmanB. J.SmigelM.NiesA. S.CarrK.WatsonJ. T.OatesJ. A. (1975). Urinary prostaglandins. Identification and origin. Journal of Clinical Investigation, 55, 763.
5.
GaddumJ. H. (1953). The technique of superfusion. British Journal of Pharmacology, 8, 321.
6.
GranströmE. (1978). Radioimmunoassay of prostaglandins. Prostaglandins, 15, 3.
7.
GranströmE.KindahlH. (1978). Radioimmunoassay of prostaglandins and thromboxanes. Advances in Prostaglandin and Thromboxane Research, 5, 119.
8.
GranströmE.SamuelssonB. (1978). Quantitative measurement of prostaglandins and thromboxanes: General considerations. Advances in Prostaglandin and Thromboxane Research, 5, 1.
9.
GréenK.HambergM.SamuelssonB.SmigelM.FrölichJ. C. (1978). Measurement of prostaglandins, thromboxanes, prostacyclin, and their metabolites by gas liquid chromatography—mass spectrometry. Advances in Prostaglandin and Thromboxane Research, 5, 39.
10.
HambergM.SamuelssonB. (1974). Prostaglandin endoperoxides VII. Novel transformations of arachidonic acid in guinea pig lung. Biochemical and Biophysical Research Communications, 61, 942.
11.
HambergM.SvenssonJ.SamuelssonB. (1975). Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proceedings of the National Academy of Sciences, 72, 2994.
12.
HawkinsH. J.SmithJ. B.NicolaouK. C.ElingT. C. (1978). Studies on the mechanism involved in the fate of prostacyclin (PGI2) and 6-keto-PGF1α in the pulmonary circulation. Prostaglandins, 16, 871.
13.
JohnsonR. A.MortonD. R.KinnerJ. H.GormanR. R.McGuireJ. C.SunF. F.WhittakerN.BuntingS.SalmonJ.MoncadaS.VaneJ. R. (1976). The chemical structure of prostaglandin X (prostacyclin). Prostaglandins, 12, 915.
14.
KindahlH.EdqvistL-E.GranströmE.BaneA. (1976). The release of prostaglandin F2α as reflected by 15-keto-13, 14-dihydroprostaglandin F2α in the peripheral circulation during normal luteolysis in heifers. Prostaglandins, 11, 871.
15.
MacloufJ.KindahlH.GranströmE.SamuelssonB. (1979). Thromboxane A2 and prostaglandin endoperoxide H2 form covalently linked derivatives with human serum albumin (Abstr.). International Conference on Prostaglandins, Washington, DC, May 1979.
16.
MoncadaS.FerreiraS. H.VaneJ. R. (1978). Bioassay of prostaglandins and biologically active substances derived from arachidonic acid. Advances in Prostaglandin and Thromboxane Research, 5, 211.
17.
MorrisonA. R.NishikawaK.NeedlemanP. (1977). Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidney. Nature, 267, 259.
18.
SamuelssonB.GranströmE.GréenK.HambergM.HammarströmS. (1975). Prostaglandins. Annual Reviews of Biochemistry44, 669.
19.
SamuelssonB.GoldyneM.GranströmE.HambergM.HammarströmS.MalmstenC. (1978). Prostaglandins and thromboxanes. Annual Reviews of Biochemistry, 47, 995.
20.
SmithJ. B.WillisA. L. (1971). Aspirin selectively inhibits prostaglandin production in human platelets. Nature (New Biology), 231, 235.
21.
VaneJ. R. (1969). The release and fate of vasoactive hormones in the circulation. British Journal of Pharmacology, 35, 209.
22.
VaneJ. R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biology), 231, 232.
23.
WongP. Y-K.MalikK. U.SunF. F.McGiffJ. C. (1978). Metabolism of prostacyclin (PGI2) in tissues of rats and rabbits. Federation Proceedings37, 1318.